Champions Oncology Inc (CSBR)
4.76
-0.05
(-1.11%)
USD |
NASDAQ |
May 16, 16:00
4.76
0.00 (0.00%)
After-Hours: 20:00
Champions Oncology Total Assets (Quarterly): 26.79M for Jan. 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 26.79M |
| October 31, 2023 | 28.29M |
| July 31, 2023 | 29.91M |
| April 30, 2023 | 34.31M |
| January 31, 2023 | 36.15M |
| October 31, 2022 | 36.36M |
| July 31, 2022 | 34.39M |
| April 30, 2022 | 35.38M |
| January 31, 2022 | 33.58M |
| October 31, 2021 | 29.30M |
| July 31, 2021 | 28.11M |
| April 30, 2021 | 27.59M |
| January 31, 2021 | 25.26M |
| October 31, 2020 | 25.76M |
| July 31, 2020 | 22.82M |
| April 30, 2020 | 20.75M |
| January 31, 2020 | 15.08M |
| October 31, 2019 | 13.95M |
| July 31, 2019 | 13.36M |
| April 30, 2019 | 11.26M |
| January 31, 2019 | 10.91M |
| October 31, 2018 | 10.24M |
| July 31, 2018 | 8.391M |
| April 30, 2018 | 8.078M |
| January 31, 2018 | 7.095M |
| Date | Value |
|---|---|
| October 31, 2017 | 6.493M |
| July 31, 2017 | 6.467M |
| April 30, 2017 | 8.011M |
| January 31, 2017 | 7.546M |
| October 31, 2016 | 8.044M |
| July 31, 2016 | 7.849M |
| April 30, 2016 | 5.777M |
| January 31, 2016 | 7.145M |
| October 31, 2015 | 7.582M |
| July 31, 2015 | 9.848M |
| April 30, 2015 | 12.05M |
| January 31, 2015 | 2.833M |
| October 31, 2014 | 3.311M |
| July 31, 2014 | 5.678M |
| April 30, 2014 | 8.867M |
| January 31, 2014 | 10.47M |
| October 31, 2013 | 10.50M |
| July 31, 2013 | 10.67M |
| April 30, 2013 | 11.65M |
| January 31, 2013 | 13.01M |
| October 31, 2012 | 4.225M |
| July 31, 2012 | 5.145M |
| April 30, 2012 | 6.922M |
| January 31, 2012 | 8.865M |
| October 31, 2011 | 9.872M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
13.36M
Minimum
Jul 2019
36.36M
Maximum
Oct 2022
27.22M
Average
28.11M
Median
Jul 2021
Total Assets (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 19.38M |
| Perspective Therapeutics Inc | 97.89M |
| Protalix BioTherapeutics Inc | 89.82M |
| Electromed Inc | 48.90M |
| Armata Pharmaceuticals Inc | 120.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.84M |
| Shareholders Equity (Quarterly) | -2.058M |
| Current Ratio | 0.6008 |